Chromocell Therapeutics Corporation/$CHRO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
Ticker
$CHRO
Sector
Trading on
AMEX
Industry
Biotechnology
Headquarters
Employees
8
ISIN
US1711261057
Website
CHRO Metrics
BasicAdvanced
$6.1M
-
-$1.24
-
-
Price and volume
Market cap
$6.1M
52-week high
$2.37
52-week low
$0.91
Average daily volume
1.4M
Financial strength
Current ratio
0.178
Quick ratio
0.026
Total debt to equity
-59.664
Interest coverage (TTM)
-25.62%
Management effectiveness
Return on assets (TTM)
-188.95%
Return on equity (TTM)
480.19%
Valuation
Price to book
-1.36
Price to tangible book (TTM)
-1.36
Price to free cash flow (TTM)
-1.239
Growth
Earnings per share change (TTM)
-69.99%
CHRO News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Chromocell Therapeutics Corporation stock?
Chromocell Therapeutics Corporation (CHRO) has a market cap of $6.1M as of May 31, 2025.
What is the P/E ratio for Chromocell Therapeutics Corporation stock?
The price to earnings (P/E) ratio for Chromocell Therapeutics Corporation (CHRO) stock is 0 as of May 31, 2025.
Does Chromocell Therapeutics Corporation stock pay dividends?
No, Chromocell Therapeutics Corporation (CHRO) stock does not pay dividends to its shareholders as of May 31, 2025.
When is the next Chromocell Therapeutics Corporation dividend payment date?
Chromocell Therapeutics Corporation (CHRO) stock does not pay dividends to its shareholders.
What is the beta indicator for Chromocell Therapeutics Corporation?
Chromocell Therapeutics Corporation (CHRO) does not currently have a Beta indicator.